Developer of transformative gene therapies designed to transform people living with devastating neurodegenerative diseases. The company's platform combines diseases such as frontotemporal dementia and...

Healthcare
London, United Kingdom
Founded 2019
65 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$148.6M
Last Round
N/A

Get the full picture

Create a free account to unlock AviadoBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required